Pacific Biosciences
PACB
PACB
160 hedge funds and large institutions have $873M invested in Pacific Biosciences in 2019 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 65 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6.85% more ownership
Funds ownership: 73.1% → 79.95% (+6.9%)
3% more funds holding
Funds holding: 155 → 160 (+5)
73% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $4.36M
Holders
160
Holding in Top 10
4
Calls
$1.19M
Puts
$4.36M
Top Buyers
| 1 | +$22.2M | |
| 2 | +$19M | |
| 3 | +$18.7M | |
| 4 |
WIC
Water Island Capital
New York
|
+$16.3M |
| 5 |
VI
Versor Investments
New York
|
+$15.2M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$18M | |
| 3 | -$15.4M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$10.5M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$7.7M |